FOCUS PI Hypromellose 0.7% Formula recall (Aurolab Trust)
DrugClass IIOngoing
Summary: Aurolab Trust is recalling FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19. Reason: Lack of Assurance of Sterility.
What is being recalled
FOCUS PI Hypromellose 0.7% Formula, 0.3 FL O (10 mL) per vial, STERILE, Manufactured for: Covalent Management, Inc., Manassas, VA 20109. NDC: 82724-007-19
Why
Lack of Assurance of Sterility
How serious is it
Class II is the middle level: using or being exposed to this product may cause temporary or medically reversible health problems, and the chance of serious harm is remote.
Where it was sold
VA (states named: Virginia)
How to tell if yours is affected
Batch# 6B093FI, Exp. 04/01/28; Batch# 6F511F1, Exp. 05/15/28
What to do
Check the product name, lot number and expiration date on your package against the codes above. If they match, do not stop taking a prescription medicine without talking to your doctor or pharmacist first; ask them about a replacement. Return or dispose of the product as your pharmacy advises.
Recall facts
| Recall number | D-0874-2026 |
| Category | Drug |
| Agency | U.S. Food and Drug Administration (FDA) |
| Severity | Class II |
| Status | Ongoing |
| Recall started | September 17, 2026 |
| Reported | October 7, 2026 |
| Company | Aurolab Trust |
| Company location | Madurai, India |
| Initiated by | Voluntary: Firm initiated |
| Quantity | 25,220 bottles |
More recalls from Aurolab Trust · all drug recalls · recalls from September 2026